Curriculum vitae Olivier Disson

Olivier DISSON

Citizenship                                French 
Professional address
:
Institut Pasteur
"Microbes and host barriers" Group
Avenir Inserm U604
25, rue du Dr Roux
75015 Paris-France
Phone: 33 1 45 68 87 62
Fax: 33 1 40 61 34 21
E-mail: odisson@pasteur.fr
Present position and status:        Chargé de Recherche niveau 2 INSERM

UNIVERSITARY EDUCATION
2004     Ph.D. in Molecular and Cellular Biology, Institute of Molecular Genetics, University of Montpellier II, France.
2001     Certificate for performing animal experimentation.
2000     Master of Biology and Health Sciences (DEA), University of Montpellier II, France.
1999     Magistere of Molecular and Cellular Biology, Ecole Normale Supérieure, Lyon, France.

RESEARCH EXPERIENCE
2008-Present     Permanent Position "Chargé de Recherche 2" Inserm, G5 "Microorganismes et barrières de l’hôte", Inserm Avenir U604 Institut Pasteur, Paris, France. "Listeria crossing of the host barriers."
2005-2008         Postdoctoral Fellow, Unité des Interactions bactéries-cellules then G5 "Microorganismes et barrières de l’hôte", Institut Pasteur, Paris, France. "Listeria crossing of the host barriers."
2004-2005         Postdoctoral Fellow, Institute of Molecular Genetics, Montpellier, France. "Roles of Brahma and Brg1 during the cell cycle."
2000-2004         Ph.D. Student, Institute of Molecular Genetics, Montpellier, France. “Modulation of apoptosis by the hepatitis C virus in a transgenic mouse model."
2000                   Second semester Master (DEA), Institute for Research and Development, Montpellier, France. "Immunomodulatory role of the Trypanosoma cruzi protein Tc52."
1999-2000         First semester Master (DEA), Institute of Human Genetic, Montpellier, France. "Sequences implied in cellular localization of the I transposon in Drosophila melanogaster."
Summer1998     Undergarduate research Student, Laboratory of altitude populations biology, Grenoble, France. "Non-invasive method for tracking Canis lupus in the Mercantour."

TEACHING
2000-2004         Practical courses of DEUG in Enzymology, Microbiology and Molecular Biology for the first and second year Students (Monitorat), University of Montpellier II, France.

ORAL COMMUNICATIONS
2003     "Control of apoptosis: Anoikis-Apoptosis in an in vivo model of hepatocarcinogenesis". European oncodeath project, Tyrolean Cancer Research Institute, Innsbruck, Austria.
2002     "Regulation of hepatocyte apoptosis in the transgenic model of HCV chronic infection". European Workshop on Cell Death, Salobrena, Spain.

PUBLICATION LIST
- Levraud JP, Disson O, Kissa K, Bonne I, Cossart P, Herbomel P, Lecuit M.
Real-time observation of Listeria-phagocyte interactions in the living zebrafish larva.
Infect Immun. 2009 Jun 22. [Epub ahead of print]

- Disson O, Nikitas G, Grayo S, Dussurget O, Cossart P, Lecuit M. Modeling human listeriosis in natural and genetically engineered animals.
Nat Protoc. 2009 4(6):799-810.

- Disson O, Grayo S, Huillet E, Nikitas G, Langa-Vives F, Dussurget O, Ragon M, Le Monnier A, Babinet C, Cossart P, Lecuit M.
Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis.
Nature. 2008 Oct 23;455(7216):1114-8

- Hippert C, Dubois G, Morin C, Disson O, Ibanes S, Jacquet C, Schwendener R, Antignac C, Kremer EJ, Kalatzis V.
Gene transfer may be preventive but not curative for a lysosomal transport disorder.
Mol Ther. 2008 Aug;16(8):1372-81.

- Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M.
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.
PLoS Pathog. 2008 Feb 8;4(2):e29.

- Coisy-Quivy M, Disson O, Roure V, Muchardt C, Blanchard JM, Dantonel JC.
Role for Brm in cell growth control.
Cancer Res. 2006 May 15;66(10):5069-76.

- Seleme MC, Disson O, Robin S, Brun C, Teninges D, Bucheton A.
In vivo RNA localization of I factor, a non-LTR retrotransposon, requires a cis-acting signal in ORF2 and ORF1 protein.
Nucleic Acids Res. 2005 Feb 1;33(2):776-85.

- Disson O, Haouzi D, Desagher S, Loesch K, Hahne M, Kremer EJ, Jacquet C, Lemon SM, Hibner U, Lerat H.
Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein.
Gastroenterology. 2004 Mar;126(3):859-72.

- Disson O, Hahne M, Hibner U, Lerat H.
Hepatocytes transgenic for the full hepatitis C virus open reading frame are resistant to fas-induced cell death.
Ann N Y Acad Sci. 2002 Nov;973:214-7.